Initial feasibility and validity of a prospective memory training program in a substance use treatment population.
Individuals with substance use disorders have shown deficits in the ability to implement future intentions, called prospective memory. Deficits in prospective memory and working memory, a critical underlying component of prospective memory, likely contribute to substance use treatment failures. Thus, improvement of prospective memory and working memory in substance use patients is an innovative target for intervention. We sought to develop a feasible and valid prospective memory training program that incorporates working memory training and may serve as a useful adjunct to substance use disorder treatment. We administered a single session of the novel prospective memory and working memory training program to participants (n = 22; 13 men, 9 women) enrolled in outpatient substance use disorder treatment and correlated performance to existing measures of prospective memory and working memory. Generally accurate prospective memory performance in a single session suggests feasibility in a substance use treatment population. However, training difficulty should be increased to avoid ceiling effects across repeated sessions. Consistent with existing literature, we observed superior performance on event-based relative to time-based prospective memory tasks. Performance on the prospective memory and working memory training components correlated with validated assessments of prospective memory and working memory, respectively. Correlations between novel memory training program performance and established measures suggest that our training engages appropriate cognitive processes. Further, differential event- and time-based prospective memory task performance suggests internal validity of our training. These data support the development of this intervention as an adjunctive therapy for substance use disorders. (PsycINFO Database Record
Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine.
Mary M
0000-0001-6931-4321
MM
Sweeney
Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine.
Olga
O
Rass
Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine.
Patrick S
PS
Johnson
Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine.
Eric C
EC
Strain
Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine.
Meredith S
MS
Berry
Mountain Manor Treatment Center.
Hoa T
HT
Vo
Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine.
Marc J
MJ
Fishman
Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine.
Cynthia A
CA
Munro
Department of Mental Health, Bloomberg School of Public Health, Johns Hopkins University.
George W
GW
Rebok
Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine.
Miriam Z
MZ
Mintzer
Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine.
Matthew W
MW
Johnson
D000328:Adult; D005240:Feasibility Studies; D005260:Female; D006801:Humans; D008297:Male; D008568:Memory; D008570:Memory, Short-Term; D011939:Mental Recall; D011446:Prospective Studies; D011613:Psychotherapy / Q000379:methods*; D015203:Reproducibility of Results; D019966:Substance-Related Disorders / Q000523:psychology / Q000628:therapy*
Neuropsychology. 2008 Jan;22(1):110-7
18211160
Neurorehabil Neural Repair. 2015 Jan;29(1):33-40
24699430
Psychopharmacology (Berl). 2009 Apr;203(3):609-16
19037633
Drug Alcohol Depend. 2013 Apr 1;129(1-2):145-50
23107600
Br J Clin Psychol. 2009 Sep;48(Pt 3):323-7
19397848
Psychol Aging. 2004 Mar;19(1):27-39
15065929
Rehabil Psychol. 2011 Feb;56(1):77-84
21401289
Psychopharmacology (Berl). 2014 Jul;231(13):2623-32
24448901
Hum Psychopharmacol. 2008 Jul;23(5):409-15
18421794
AIDS. 1991 Feb;5(2):181-5
2031690
J Addict Med. 2011 Mar;5(1):1-8
21321675
Psychol Bull. 2002 Jul;128(4):612-37
12081085
Q J Exp Psychol (Hove). 2010 Mar;63(3):442-51
20043274
J Clin Exp Neuropsychol. 2007 Jul;29(5):496-504
17564915
Addiction. 2012 Oct;107(10):1809-16
22578026
Biol Psychiatry. 2011 Feb 1;69(3):260-5
20965498
Science. 1992 Jan 31;255(5044):556-9
1736359
Drug Alcohol Depend. 2010 Jun 1;109(1-3):73-8
20071106
J Psychoactive Drugs. 2015 Sep-Oct;47(4):301-7
26375411
Hum Psychopharmacol. 2001 Dec;16(8):619-625
12404542
Hum Psychopharmacol. 2012 Mar;27(2):217-25
22389086
Memory. 2001 Jan;9(1):1-11
11315657
PLoS One. 2015 May 27;10(5):e0128641
26017273
J Clin Exp Neuropsychol. 2005 Feb;27(2):189-204
15903150
Drug Alcohol Depend. 2002 Jun 1;67(1):41-51
12062778
Psychol Sci. 2011 Jul;22(7):968-75
21685380
J Exp Psychol Learn Mem Cogn. 1995 Jul;21(4):996-1007
7673871
J Behav Med. 2012 Feb;35(1):47-62
21487722
Games Health J. 2015 Apr;4(2):136-44
26181807
Neuropsychology. 2003 Apr;17(2):283-8
12803434
Exp Psychol. 2005;52(4):243-56
16304724
Schizophr Res. 2015 Dec;169(1-3):147-152
26404040
Drug Alcohol Depend. 2015 Nov 1;156:38-46
26404954
Psychopharmacology (Berl). 2007 Nov;194(4):497-504
17619860
Memory. 1997 Jul;5(4):483-507
9282220
J Exp Psychol Learn Mem Cogn. 2003 May;29(3):347-61
12776746
Curr Drug Abuse Rev. 2008 Jan;1(1):36-41
19630703
Trials. 2015 Apr 29;16:196
25927718
Neuropsychobiology. 2009;60(3-4):159-75
19893333
Hum Psychopharmacol. 2001 Dec;16(8):607-612
12404540
Psychol Res. 2014 Nov;78(6):892-904
24744122
Compr Psychiatry. 1993 Nov-Dec;34(6):375-83
8131381
Neuropsychopharmacology. 2000 Aug;23(2):113-26
10882838
J Clin Psychol. 1985 Nov;41(6):820-31
4078008
J Psychopharmacol. 2010 Feb;24(2):241-6
19825904
Can J Exp Psychol. 2011 Mar;65(1):57-68
21443331
Psychopharmacology (Berl). 2013 Jun;227(3):377-84
23344557
Alcohol Alcohol. 2002 May-Jun;37(3):269-71
12003916
J Exp Psychol Learn Mem Cogn. 1990 Jul;16(4):717-26
2142956